render_searchpagetitle(); ?> render_searchpagemetatags(); ?>
Search - Add URL - Join The Lab
Found 1740 results for the keyword in patients. Time 0.007 seconds.
RINVOQ® (upadacitinib) for Atopic DermatitisLearn about RINVOQ® (upadacitinib), a JAK inhibitor for the treatment of refractory, moderate to severe Atopic Dermatitis (AD) in patients 12+ years. See full Prescribing Information and Important Safety Information, inc
Minimize Vap in PatientsClosed System with 3 Replaceable Catheters, Minimizes the need for entire system replacement, thereby reducing the risk of Ventilator Associated Pneumonia (Vap)
RINVOQ® (upadacitinib) for Psoriatic ArthritisLearn about RINVOQ® (upadacitinib) for the treatment of active Psoriatic Arthritis (PsA) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
RINVOQ® (upadacitinib) for Ulcerative ColitisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Ulcerative Colitis (UC) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
SKYRIZI® (risankizumab-rzaa) HCP - Official Site by AbbVie Inc.A biologic treatment for adult patients living with moderate to severe Plaque Psoriasis, adults with active Psoriatic Arthritis, adults with moderate to severe active Crohn s Disease, and adults with moderate to severe U
RINVOQ® (upadacitinib) - Official Healthcare Professional SiteLearn about RINVOQ® (upadacitinib), approved for RA, PA, pJIA, AD, UC, AS, nr-axSpA, and CD. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
RINVOQ® (upadacitinib) for Rheumatoid ArthritisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Rheumatoid Arthritis (RA) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
JUVEDERM® Dermal Filler Collection | HCPJUVEDERM® Collection of Fillers is the #1 chosen dermal filler collection worldwide. Specifically designed to meet your patients needs.
BL-M07D1 / Biokin PharmaNews for BL-M07D1 / Biokin Pharma
HUMIRA® (adalimumab) | For Healthcare ProfessionalsHUMIRA is indicated for the treatment of rheumatology, dermatology, and gastroenterology indications. Review efficacy, safety data, and more.
|
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less | ||
To process your query we did a search for the keyphrases in patients << Previous - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - Next >> |
Didn't find what you were searching for? You can add a new website to the index, remove your site from the search results using the robots.txt protocol or tell us how you would like the results by sending us a message using the email address below:
|
Recent searches:
Bfs - N g - salt trick - Rapid Profits - digital marketing
central monitoring services - and 4 bedroom - google - simd - packaging machinery
Copyright (C) 2007 - 2025 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login